Tirzepatide Mechanism: Complete Scientific Guide
15 min read
Share:
Published almost 2 years ago
Table of Contents
Key Takeaways
- • Tirzepatide mimics both GLP-1 and GIP hormones for enhanced weight loss
- • Dual-action mechanism provides advantages over single GLP-1 agonists
- • Clinical trials show 15-22% average weight loss over 72 weeks
- • Slows gastric emptying, promoting satiety and reducing food intake
The Dual Mechanism Explained
Tirzepatide works through two complementary pathways by mimicking both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) hormones.
Ready to Start Your Weight Loss Journey?
Get started with physician-guided GLP-1 treatment from the comfort of your home.
Get Started TodayTMT
Written by Trimi Medical Team
Our team of healthcare professionals specializes in weight management and metabolic health, providing evidence-based information to help you make informed decisions about your health journey.